Advancing Tomorrow’s Cancer Medicines: Jacob Van Naarden Talks with Ken Herrmann and Johannes Czernin About Corporate Approaches to New Therapeutics Development

By sjmartinez • January 24, 2025

Van Naarden JS, Herrmann K, Czernin J. Advancing Tomorrow's Cancer Medicines: Jacob Van Naarden Talks with Ken Herrmann and Johannes Czernin About Corporate Approaches to New Therapeutics Development. J Nucl Med. 2025 Jan 23:jnumed.124.269354. doi: 10.2967/jnumed.124.269354. Epub ahead of print. PMID: 39848767.

Tags: Cardiology/Epi, Publications

Amara Yad Image: The Tricuspid Valve

Shivkumar K. Amara Yad Image: The Tricuspid Valve. J Am Coll Cardiol. 2025 Jan 28;85(3):295-296. doi: 10.1016/j.jacc.2024.12.026. PMID: 39843032.

Association of neighborhood-level socioeconomic disadvantage and Life’s Essential 8 in early pregnancy

Venkatesh KK, Grobman WA, Huang X, Yee LM, Catov J, Simhan H, Haas DM, Mercer B, Reddy U, Silver RM, Levine LD, Chung J, Saade[...]

MRI-assessed Dynamic Hyperinflation Induced by Tachypnea in Chronic Obstructive Pulmonary Disease: The SPIROMICS-HF Study

Zhang X, Cooper CB, Prince MR, Ambale-Venkatesh B, Agarwal PP, Backman MC, Bluemke DA, Couper D, Dashnaw SM, Finn JP, Hansel NN, Hoffman EA, Jambawalikar[...]